Work

Pilot study combining PD-L1 antibody durvalumab (D) with CTLA-4 antibody tremelimumab (T) and stereotactic body radiotherapy (SBRT) to treat metastatic anaplastic thyroid cancer (ATC).

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.6088

Authors: Eric Jeffrey Sherman, C. Jillian Tsai, Wanqing Iris Zhi, James Vincent Fetten, Vanessa Wu, Alan Loh Ho, Nadeem Riaz, David G. Pfister, Nancy Y. Lee

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Thyroid Cancer Diagnosis and Treatment

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2946932530

Cites:

Cited by: 11

Related to: 10